Abstract
Interstitial lung disease (ILD) associated with connective tissue diseases (CTDs) is highly heterogeneous in its clinical presentation and course. The diagnosis and management of CTD-ILD require a multidisciplinary approach involving, at minimum, a rheumatologist, a pulmonologist, and a radiologist. Close monitoring of patients with CTD-ILD is important to enable early detection of disease progression and inform decisions regarding the initiation or escalation of pharmacotherapy. In the absence of guidelines regarding how CTD-ILDs should be treated, clinicians face difficult decisions on when to use immunosuppressant and anti-fibrotic therapies. The importance of a multidisciplinary and individualized approach to the diagnosis and management of CTD-ILD is highlighted in the three case studies that we describe in this article.
Cite
CITATION STYLE
Koslow, M., Maleki-Fischbach, M., & Keith, R. C. (2021). Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases. Case Reports in Rheumatology, 2021, 1–7. https://doi.org/10.1155/2021/6677353
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.